Cybrid human embryos--warranting opportunities to augment embryonic stem cell research
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
British Heart Foundation - United Kingdom
Medical Research Council - United Kingdom
PubMed
18675481
DOI
10.1016/j.tibtech.2008.06.001
PII: S0167-7799(08)00173-X
Knihovny.cz E-resources
- MeSH
- Cell Line MeSH
- Embryo, Mammalian cytology physiology MeSH
- Embryonic Stem Cells cytology MeSH
- Cloning, Organism ethics MeSH
- Humans MeSH
- Multipotent Stem Cells cytology metabolism MeSH
- Embryo Disposition ethics MeSH
- Oocytes cytology MeSH
- Cellular Reprogramming physiology MeSH
- Nuclear Transfer Techniques ethics legislation & jurisprudence trends MeSH
- Totipotent Stem Cells cytology metabolism MeSH
- Research Embryo Creation ethics legislation & jurisprudence methods MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The recent vote in the British Parliament allows scientists in principle to create hybrid embryos by transferring human somatic cell nuclei into animal oocytes. This vote opens a fascinating new area of research with the central aim of generating interspecific lines of embryonic stem cells (ESCs) that could potentially be used to understand development, differentiation, gene expression and genomic compatibility. It will also promote human cell therapies, as well as the pharmaceutical industry's search for new drug targets. If this approach is to be successful, many biological questions need to be answered and, in addition, some moral and ethical aspects must be taken into account.
References provided by Crossref.org